Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Completed · Phase 1/Phase 2

Conditions studied: Ewing's Sarcoma Family of Tumors

In brief

Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors

Key facts

Study ID

NCT00560235

Run by

Pfizer

People needed

138

Starts

2008-03-01

Expected to finish

2012-10-01

Last updated by the study team

2015-10-28

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ewing's family of tumors
• Current disease state for which there is no curative therapy

You may not qualify if…

• Prior anti-IGF-1R therapy
• Concurrent treatment with other anti-cancer agents

Where it is running

• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Rochester, Minnesota, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States
• Pfizer Investigational Site — Providence, Rhode Island, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Seattle, Washington, United States
• Pfizer Investigational Site — Brisbane, Queensland, Australia
• Pfizer Investigational Site — Parkville, Victoria, Australia
• Pfizer Investigational Site — São Paulo, São Paulo, Brazil
• Pfizer Investigational Site — Toronto, Ontario, Canada
• Pfizer Investigational Site — Providencia, Santiago, RM, Chile
• Pfizer Investigational Site — Lille, France
• Pfizer Investigational Site — Lyon, France
• Pfizer Investigational Site — Paris, France
• Pfizer Investigational Site — Villejuif, France
• Pfizer Investigational Site — Berlin, Germany
• Pfizer Investigational Site — Freiburg im Breisgau, Germany
• Pfizer Investigational Site — München, Germany
• Pfizer Investigational Site — Münster, Germany
• Pfizer Investigational Site — Jerusalem, Israel
• Pfizer Investigational Site — Petah Tikva, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.